ATM and the Mre11-Rad50-Nbs1 complex respond to nucleoside analogue-induced stalled replication forks and contribute to drug resistance
- PMID: 18829552
- PMCID: PMC2631429
- DOI: 10.1158/0008-5472.CAN-08-0971
ATM and the Mre11-Rad50-Nbs1 complex respond to nucleoside analogue-induced stalled replication forks and contribute to drug resistance
Abstract
The Mre11-Rad50-Nbs1 complex and autophosphorylated Ser(1981)-ATM are involved in recognizing and repairing DNA damage, such as double-strand breaks (DSB). However, the role of these factors in response to stalled replication forks is not clear. Nucleoside analogues are agents that are incorporated into DNA during replication, which cause stalling of replication forks. The molecular mechanisms that sense these events may signal for DNA repair and contribute to survival but are poorly understood. Cellular responses to both DSBs and stalled replication forks are marked by H2AX phosphorylation on Ser(139) (gamma-H2AX), which forms nuclear foci at sites of DNA damage. Here, concentrations of the nucleoside analogues 1-beta-d-arabinofuranosylcytosine (cytarabine; ara-C), gemcitabine, and troxacitabine, which inhibited DNA synthesis by 90% within 2 hours, were determined for each agent. Using gamma-H2AX as a marker for changes in chromatin structure, we show that Mre11, Rad50, Nbs1, and phosphorylated ATM respond to nucleoside analogue-induced stalled replication forks by forming nuclear foci that colocalize with gamma-H2AX within 2 hours. Because neither DSBs nor single-strand breaks were detectable after nucleoside analogue exposure, we conclude that this molecular response is not due to the presence of DNA breaks. Deficiencies in ATM, Mre11, or Rad50 led to a 2- to 5-fold increase in clonogenic sensitization to gemcitabine, whereas Nbs1 and H2AX deficiency did not affect reproductive growth. Taken together, these results suggest that ATM, Mre11, and Rad50 are required for survival after replication fork stalling, whereas Nbs1 and H2AX are inconsequential.
Figures





Similar articles
-
Defective Mre11-dependent activation of Chk2 by ataxia telangiectasia mutated in colorectal carcinoma cells in response to replication-dependent DNA double strand breaks.J Biol Chem. 2006 Oct 13;281(41):30814-23. doi: 10.1074/jbc.M603747200. Epub 2006 Aug 10. J Biol Chem. 2006. PMID: 16905549
-
Ataxia telangiectasia-mutated (ATM) kinase activity is regulated by ATP-driven conformational changes in the Mre11/Rad50/Nbs1 (MRN) complex.J Biol Chem. 2013 May 3;288(18):12840-51. doi: 10.1074/jbc.M113.460378. Epub 2013 Mar 22. J Biol Chem. 2013. PMID: 23525106 Free PMC article.
-
A mutant allele of MRE11 found in mismatch repair-deficient tumor cells suppresses the cellular response to DNA replication fork stress in a dominant negative manner.Mol Biol Cell. 2008 Apr;19(4):1693-705. doi: 10.1091/mbc.e07-09-0975. Epub 2008 Feb 6. Mol Biol Cell. 2008. PMID: 18256278 Free PMC article.
-
MRE11/RAD50/NBS1: complex activities.Chromosoma. 2004 Oct;113(4):157-66. doi: 10.1007/s00412-004-0306-4. Epub 2004 Aug 10. Chromosoma. 2004. PMID: 15309560 Review.
-
Mre11-Rad50-Nbs1 is a keystone complex connecting DNA repair machinery, double-strand break signaling, and the chromatin template.Biochem Cell Biol. 2007 Aug;85(4):509-20. doi: 10.1139/O07-069. Biochem Cell Biol. 2007. PMID: 17713585 Review.
Cited by
-
Acquired temozolomide resistance in MGMTlow gliomas is associated with regulation of homologous recombination repair by ROCK2.Cell Death Dis. 2022 Feb 10;13(2):138. doi: 10.1038/s41419-022-04590-6. Cell Death Dis. 2022. PMID: 35145081 Free PMC article.
-
Homologous recombination as a resistance mechanism to replication-induced double-strand breaks caused by the antileukemia agent CNDAC.Blood. 2010 Sep 9;116(10):1737-46. doi: 10.1182/blood-2009-05-220376. Epub 2010 May 17. Blood. 2010. PMID: 20479284 Free PMC article.
-
Plk1 inhibition enhances the efficacy of gemcitabine in human pancreatic cancer.Cell Cycle. 2016;15(5):711-9. doi: 10.1080/15384101.2016.1148838. Cell Cycle. 2016. PMID: 26890815 Free PMC article.
-
Requirement for NBS1 in the S phase checkpoint response to DNA methylation combined with PARP inhibition.DNA Repair (Amst). 2011 Feb 7;10(2):225-34. doi: 10.1016/j.dnarep.2010.11.003. Epub 2010 Dec 3. DNA Repair (Amst). 2011. PMID: 21130714 Free PMC article.
-
The human immunodeficiency virus protease inhibitor ritonavir inhibits lung cancer cells, in part, by inhibition of survivin.J Thorac Oncol. 2011 Apr;6(4):661-70. doi: 10.1097/JTO.0b013e31820c9e3c. J Thorac Oncol. 2011. PMID: 21270666 Free PMC article.
References
-
- Paulsen RD, Cimprich KA. The ATR pathway: fine-tuning the fork. DNA Repair (Amst) 2007;6:953–66. - PubMed
-
- Sampath D, Rao VA, Plunkett W. Mechanisms of apoptosis induction by nucleoside analogs. Oncogene. 2003;22:9063–74. - PubMed
-
- Sampath D, Shi Z, Plunkett W. Inhibition of cyclin-dependent kinase 2 by the Chk1-Cdc25A pathway during the S-phase checkpoint activated by fludarabine: dysregulation by 7-hydroxystaurosporine. Mol Pharmacol. 2002;62:680–8. - PubMed
-
- Ewald B, Sampath D, Plunkett W. H2AX phosphorylation marks gemcitabine-induced stalled replication forks and their collapse upon S-phase checkpoint abrogation. Mol Cancer Ther. 2007;6:1239–48. - PubMed
-
- Shiloh Y. The ATM-mediated DNA-damage response: taking shape. Trends Biochem Sci. 2006;31:402–10. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Research Materials
Miscellaneous